FDA says Prilosec can block benefits of Plavix

Federal health officials said Tuesday a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.

Go to Source

People who read this also read

• FDA warns that heartburn drugs Prilosec, Nexium block benefits of blood thinner Plavix
  more images more images FDA says heartburn drugs can interfere with Plavix WASHINGTON — Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke. ...
• FDA warns that heartburn drug Prilosec can block benefits of blood thinner Plavix
  more images more images FDA says Prilosec can block benefits of Plavix WASHINGTON — Federal health officials say a popular heartburn medication can block the blood thinning effect of Plavix, which is taken by millions of Americans to reduce risks of heart attack and stroke. The Food and Drug Admi...
• FDA Announces New Boxed Warning On Plavix
  The U.S. Food and Drug Administration added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form. Plavix reduces the risk of...
• A Black-Box Warning for Plavix. Confusion May Follow
  The FDA says it added its strongest warning today to the label of the widely used bloodthinner Plavix, Bristol-Myers’ best-selling drug, to help physicians treat patients correctly. But the warning could make doctors’ job more difficult. Docs prescribe Plavix to reduce the risk of heart...
• New Analysis Showed Effient(R) Cost-Effective Compared With Clopidogrel For Patients With Acute Coronary Syndromes Undergoing PCI
  Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) w...